IDEAYA Biosciences clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   Adjuvant Darovasertib and Crizotinib · Primary Non-metastatic Uveal…Adjuvant Darovasertib and Crizotinib · Primary Non-metastatic Uveal Melanoma

   Trial sites expanded: 1 → 13 locations

   IDEAYA Biosciences·Phase 3· NCT07804186· Registry history of NCT07804186 on ClinicalTrials.gov (opens the registry)

   Updated Sep 15, 2026

2. Minor

   IDE892 as Monotherapy and Combination in MTAP-deleted Advanced…IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

   Trial sites expanded: 17 → 20 locations

   IDEAYA Biosciences·Phase 1· NCT07277413· Registry history of NCT07277413 on ClinicalTrials.gov (opens the registry)

   Updated Sep 18, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.